Stocklytics Platform
Asset logo for symbol AXGN
AxoGen
AXGN76
$16.26arrow_drop_down5.43%-$0.93
High Growth
Asset logo for symbol AXGN
AXGN76

$16.26

arrow_drop_down5.43%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

AxoGen (AXGN) Stocklytics Forecast

AxoGen Inc (AXGN) is a medical technology company that specializes in the development and commercialization of innovative surgical solutions for peripheral nerve injuries. The company's flagship product, AxoGuard Nerve Connector, is a bioresorbable collagen tube that provides a protective environment for nerve regeneration. AxoGen's other products include AxoGuard Nerve Protector and Avance Nerve Graft, both of which are used in nerve reconstruction procedures.
The stock price of AxoGen Inc (AXGN) has shown significant growth in recent years, and many investors are curious about its future potential. While it is impossible to predict the exact stock price for any company, there are several factors that may contribute to the future performance of AxoGen Inc. One important factor is the company's financial performance and potential for revenue growth. AxoGen has demonstrated strong revenue growth in recent years, with year-over-year revenue increasing by double-digit percentages. This suggests that the company's products are in high demand and that there is potential for further growth in the future.
add AxoGen  to watchlist

Keep an eye on AxoGen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for AxoGen (AXGN) stock?

Analysts have set a target price of $21.4 for AxoGen (AXGN), based on forecasts from 15 analysts. The predicted price range extends from a high of $45 to a low of $9. This represents a potential increase of up to 176.75% and a decrease of -44.65% from the current price of $16.26. These forecasts are as of 2018 Mar 01.
help

What are the analyst ratings for AxoGen (AXGN) stock?

The analyst ratings for AxoGen (AXGN) are distributed as follows: 6 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering AxoGen .
help

What is the AI price prediction for AxoGen (AXGN) stock?

At present, there is no AI or machine-learning-based price prediction available for AxoGen (AXGN) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level